MedPath

Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

Phase 3
Completed
Conditions
Asthma
Interventions
Registration Number
NCT00073827
Lead Sponsor
Sumitomo Pharma America, Inc.
Brief Summary

The primary purpose of this study was to investigate the efficacy of levalbuterol compared to a placebo and compared to albuterol in the treatment and prevention of bronchoconstriction in adolescent and adult subjects with asthma, with all treatments administered 4 times a day (QID).

Detailed Description

This was a Phase III, multicenter, randomized, double-blind, placebo- and active-controlled, parallel-group study of up to 9 weeks in duration. Seven days of QID single-blind placebo administration (via MDI) was followed by 56 days of QID double-blind active treatment. Following the run-in period, each subject was randomized to one of the following three treatments: levalbuterol HFA MDI 90 mcg (2 actuations of 45 mcg), racemic albuterol HFA MDI 180 mcg (2 actuations of 90 mcg), or placebo (2 actuations). Subjects were randomized in a 2:1:1 ratio of levalbuterol to racemic albuterol to placebo. In order to maintain blinding of the device, a placebo dose was administered with each treatment. This study was previously posted by Sepracor Inc. In October 2009, Sepracor Inc. was acquired by Dainippon Sumitomo Pharma., and in October 2010, Sepracor Inc's name was changed to Sunovion Pharmaceuticals Inc.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
445
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1levalbuterol tartrate MDIlevalbuterol MDI 90 mcg QID
2racemic albuterol MDIracemic albuterol MDI 180 mcg QID
3PlaceboPlacebo MDI QID
Primary Outcome Measures
NameTimeMethod
percent change in FEV1 from visit predose averaged over the 8-week double-blind periodWeeks 0, 4, 8
Secondary Outcome Measures
NameTimeMethod
area under the FEV1 percent change curve from visit pre-dose and from study baseline curves averaged over the double-blind periodWeeks 0, 4, 8
peak percent change in FEV1 from study baselineWeeks 0, 4, 8
peak change in FEV1 from visit predoseWeeks 0, 4, 8
peak percent of predicted FEV1Weeks 0, 4, 8
area under the FEV1 curve (AUC)Weeks 0, 4, 8
peak change and peak percent change in FEF25-75% from visit predoseWeeks 0, 4, 8
peak change and peak percent change in FVC from visit predoseWeeks 0, 4, 8

Trial Locations

Locations (63)

Clinical Research Centers of Colorado PC

🇺🇸

Englewood, Colorado, United States

University of Maryland School of Medicine

🇺🇸

Baltimore, Maryland, United States

Princeton Center for Clinical Research

🇺🇸

Princeton, New Jersey, United States

Asthma & Allergy Associates, PC

🇺🇸

Pueblo, Colorado, United States

Regional Allergy & Asthma Consultants

🇺🇸

Asheville, North Carolina, United States

Allergy Research Foundation, Inc.

🇺🇸

Los Angeles, California, United States

Children's Hospital of Pittsburgh Division of Allergy, Immunology & Infectious Diseases

🇺🇸

Pittsburgh, Pennsylvania, United States

University of Pittsburgh Division of Pulmonary

🇺🇸

Pittsburgh, Pennsylvania, United States

ASTHMA, Inc.

🇺🇸

Seattle, Washington, United States

Clinical Research Center of Indiana

🇺🇸

Indianapolis, Indiana, United States

Breath of Life Research Institute

🇺🇸

Houston, Texas, United States

Allergy, Asthma & Respiratory Care Center

🇺🇸

Long Beach, California, United States

MDC Research

🇺🇸

Mobile, Alabama, United States

Allergy & Asthma Medical Group of Diablo Valley, Inc.

🇺🇸

Danville, California, United States

Radiant Research, Inc.

🇺🇸

Encinitas, California, United States

Allergy & Asthma Specialists Medical Group

🇺🇸

Huntington Beach, California, United States

Office of Ronald Saff

🇺🇸

Tallahassee, Florida, United States

The Clinical Research Center, LLC

🇺🇸

St. Louis, Missouri, United States

Allergy & Asthma Research Associates

🇺🇸

Dallas, Texas, United States

Office of Constantine Saadeh

🇺🇸

Amarillo, Texas, United States

Clinical Trials of Orange County

🇺🇸

Orange, California, United States

Alabama Asthma and Allergy Center

🇺🇸

Homewood, Alabama, United States

Integrated Research Group

🇺🇸

Corona, California, United States

Aeroallergy Research Laboratories of Savannah, Inc.

🇺🇸

Savannah, Georgia, United States

Allergy & Asthma Assoc. of Santa Clara Valley Research Center

🇺🇸

San Jose, California, United States

Southern California Research Center

🇺🇸

Viejo, California, United States

Bensch Research Associates

🇺🇸

Stockton, California, United States

Radiant Research Honolulu

🇺🇸

Honolulu, Hawaii, United States

Northshore Medical Research

🇺🇸

Slidell, Louisiana, United States

Mississippi Asthma & Allergy Clinic

🇺🇸

Jackson, Mississippi, United States

Allergy & Asthma Care Specialists

🇺🇸

Metairie, Louisiana, United States

PCHI

🇺🇸

Needham, Massachusetts, United States

Northeast Medical Research Associates, Inc.

🇺🇸

N. Dartmouth, Massachusetts, United States

PCCS

🇺🇸

Albany, New York, United States

Center for Clinical Research

🇺🇸

Taunton, Massachusetts, United States

Division of Allergy & Immunology, Washington Univ School of Med

🇺🇸

St. Louis, Missouri, United States

Office of Clinical Research, University of Missouri-Columbia

🇺🇸

Columbia, Missouri, United States

AAIR Research Center

🇺🇸

Rochester, New York, United States

Pulmonary and Allergy Associates

🇺🇸

Springfield, New Jersey, United States

Allergy & Asthma Research

🇺🇸

Eugene, Oregon, United States

Raleigh Pediatric Associates

🇺🇸

Raleigh, North Carolina, United States

Cornerstone Research Care

🇺🇸

High Point, North Carolina, United States

Asthma & Allergy Research Associates

🇺🇸

Chester, Pennsylvania, United States

Temple University Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

Office of Neil Kao

🇺🇸

Greenville, South Carolina, United States

Allergy & Asthma Consultants, LLP

🇺🇸

Mt. Pleasant, South Carolina, United States

Children's Hospital of the Kings Daughters

🇺🇸

Norfolk, Virginia, United States

Allergy & Asthma Center

🇺🇸

Waco, Texas, United States

North Texas Institute for Clinical Trials

🇺🇸

Fort Worth, Texas, United States

Allergic Diseases, SC

🇺🇸

West Allis, Wisconsin, United States

Pulmonary Associates of Richmond, Inc.

🇺🇸

Richmond, Virginia, United States

St. Louis University

🇺🇸

St. Louis, Missouri, United States

Allergy Associates Medical Group

🇺🇸

San Diego, California, United States

Allergy & Asthma Medical Group & Research Center

🇺🇸

San Diego, California, United States

Allergy & Asthma Prevention & Treatment Center

🇺🇸

San Diego, California, United States

National Jewish Medical & Research Center

🇺🇸

Denver, Colorado, United States

Henry Ford Health System

🇺🇸

Detroit, Michigan, United States

Clinical Research Institute

🇺🇸

Minneapolis, Minnesota, United States

The Children's Mercy Hospital

🇺🇸

Kansas City, Missouri, United States

Bernstein Clinical Research Center, LLC

🇺🇸

Cincinnati, Ohio, United States

Allergy Associates Research Center, LLC

🇺🇸

Portland, Oregon, United States

Lung Diagnostics

🇺🇸

San Antonio, Texas, United States

Radiant Research

🇺🇸

Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath